IGM Biosciences
Utility Patents

Last updated:

List of all IGM Biosciences patents 12 in total

Status Patent
Grant
Utility: Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function External link
Filling date: 26 Sep 2025 Issue date: 2 Aug 2022
Grant
Utility: Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 7 Dec 2021
Grant
Utility: Modified J-chain External link
Filling date: 26 Sep 2025 Issue date: 13 Apr 2021
Grant
Utility: Anti-PD-L1 antibodies External link
Filling date: 26 Sep 2025 Issue date: 23 Mar 2021
Grant
Utility: IgM Fc and J-chain mutations that affect IgM serum half-life External link
Filling date: 26 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: IgA multi-specific binding molecules External link
Filling date: 26 Sep 2025 Issue date: 3 Nov 2020
Grant
Utility: Multimeric bispecific binding molecules specific for CD20 and CD3 External link
Filling date: 26 Sep 2025 Issue date: 29 Sep 2020
Grant
Utility: Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 23 Jun 2020
Grant
Utility: Binding molecules with modified J-chain External link
Filling date: 26 Sep 2025 Issue date: 14 Apr 2020
Grant
Utility: Multi-valent hepatitis B virus antigen binding molecules and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 31 Mar 2020
Grant
Utility: Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: Modified J-chain External link
Filling date: 26 Sep 2025 Issue date: 3 Sep 2019

Showing 1 to 12 of 12 patents.